UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 137

Sortiert nach

Latent tuberculosis infection: Opportunities and challenges

Respirology (Carlton, Vic.), 2018-10, Vol.23 (10), p.893-900

2018

Volltextzugriff (PDF)

Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy

PloS one, 2013-01, Vol.8 (1), p.e53373

2013

Volltextzugriff (PDF)

Our Love–Hate Relationship With Pyrazinamide

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e3518-e3519

Reves, Randall

2021

Volltextzugriff (PDF)

Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens

PloS one, 2011-11, Vol.6 (11), p.e26545-e26545

2011

Volltextzugriff (PDF)

Interferon-γ Release Assays in Children <15 Years of Age

Pediatrics (Evanston), 2020-01, Vol.145 (1), p.1

2020

Volltextzugriff (PDF)

Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection

Journal of clinical microbiology, 2017-02, Vol.55 (2), p.391-402

2017

Volltextzugriff (PDF)

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis

American journal of respiratory and critical care medicine, 2003-02, Vol.167 (4), p.603-662

2003

Volltextzugriff (PDF)

High Rates of Tuberculosis and Opportunities for Prevention among International Students in the United States

Annals of the American Thoracic Society, 2016-04, Vol.13 (4), p.522-528

2016

Volltextzugriff (PDF)

Tuberculosis elimination in the United States: an achievable goal or an illusion?

American journal of respiratory and critical care medicine, 2012-08, Vol.186 (3), p.i-iii

2012

Volltextzugriff (PDF)

Prospective Comparison of the Tuberculin Skin Test and 2 Whole-Blood Interferon-γ Release Assays in Persons with Suspected Tuberculosis

Clinical infectious diseases, 2007-10, Vol.45 (7), p.837-845

2007

Volltextzugriff (PDF)

Review of False-Positive Cultures for Mycobacterium tuberculosis and Recommendations for Avoiding Unnecessary Treatment

Clinical infectious diseases, 2000-12, Vol.31 (6), p.1390-1395

2000

Volltextzugriff (PDF)

Finding and Closing the Gaps in the Tuberculosis Elimination Campaign

Annals of the American Thoracic Society, 2020-11, Vol.17 (11), p.1376-1377

Reves, Randall

2020

Volltextzugriff (PDF)

Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination

PloS one, 2013-12, Vol.8 (12), p.e82727

2013

Volltextzugriff (PDF)

Breaking the camel's back: multicenter clinical trials and local institutional review boards

Annals of internal medicine, 2001-01, Vol.134 (2), p.152

2001

Volltextzugriff (PDF)

A Summary of Meeting Proceedings on Addressing Variability around the Cut Point in Serial Interferon-γ Release Assay Testing

Infection control and hospital epidemiology, 2013-06, Vol.34 (6), p.625-630

2013

Volltextzugriff (PDF)

Is it time to rethink the role of AFB smears?

The international journal of tuberculosis and lung disease, 2017-07, Vol.21 (7), p.720

2017

Volltextzugriff (PDF)

Early clinical experience with networked system for promoting patient self-management

The American journal of managed care, 2011-07, Vol.17 (7), p.e277-e287

2011

Volltextzugriff (PDF)

Sorting out icebergs, mirages, and clinical tuberculosis during active case finding

American journal of respiratory and critical care medicine, 2009-12, Vol.180 (12), p.1167-1169

2009

Volltextzugriff (PDF)

The cost of the failure to eliminate tuberculosis in the United States

The international journal of tuberculosis and lung disease, 2017-01, Vol.21 (1), p.120

2017

Volltextzugriff (PDF)

Strong Community-Public Health Partnerships May Help Us Move Closer to Tuberculosis Elimination

American journal of public health (1971), 2019-07, Vol.109 (7), p.958-959

2019

Volltextzugriff (PDF)

Skin-test screening and tuberculosis transmission among the homeless

Emerging infectious diseases, 2002-11, Vol.8 (11), p.1280-1284

2002

Volltextzugriff (PDF)

Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates

The American journal of medicine, 2003-10, Vol.115 (5), p.358-364

2003

Volltextzugriff (PDF)

Persistent latent tuberculosis reactivation risk in United States immigrants

American journal of respiratory and critical care medicine, 2014-01, Vol.189 (1), p.88-95

2014

Volltextzugriff (PDF)

Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers

American journal of respiratory and critical care medicine, 2001-10, Vol.164 (7), p.1112-1113

2001

Volltextzugriff (PDF)

Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States

American journal of respiratory and critical care medicine, 2014-01, Vol.189 (1), p.77-87

2014

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(109)

Publikationsform

Artikel
(136)
Buchkapitel
(1)

Sprache

Englisch
(137)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Latent tuberculosis infection: Opportunities and challenges

Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy

Our Love–Hate Relationship With Pyrazinamide

Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens

Interferon-γ Release Assays in Children <15 Years of Age

Highly Multiplexed Proteomic Analysis of Quantiferon Supernatants To Identify Biomarkers of Latent Tuberculosis Infection

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis

High Rates of Tuberculosis and Opportunities for Prevention among International Students in the United States

Tuberculosis elimination in the United States: an achievable goal or an illusion?

Prospective Comparison of the Tuberculin Skin Test and 2 Whole-Blood Interferon-γ Release Assays in Persons with Suspected Tuberculosis

Review of False-Positive Cultures for Mycobacterium tuberculosis and Recommendations for Avoiding Unnecessary Treatment

Finding and Closing the Gaps in the Tuberculosis Elimination Campaign

Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination

Breaking the camel's back: multicenter clinical trials and local institutional review boards

A Summary of Meeting Proceedings on Addressing Variability around the Cut Point in Serial Interferon-γ Release Assay Testing

Is it time to rethink the role of AFB smears?

Early clinical experience with networked system for promoting patient self-management

Sorting out icebergs, mirages, and clinical tuberculosis during active case finding

The cost of the failure to eliminate tuberculosis in the United States

Strong Community-Public Health Partnerships May Help Us Move Closer to Tuberculosis Elimination

Skin-test screening and tuberculosis transmission among the homeless

Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates

Persistent latent tuberculosis reactivation risk in United States immigrants

Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers

Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States

Suchergebnisse filtern